<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>SE-0-SE-6-5119011101-ZMB-12220</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">TA f&#xF6;r Medical Stores Limited</narrative>
   <narrative xml:lang="SV">TA to Medical Stores Limited</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="SV">Bidraget st&#xF6;der satsningen nummer 51190097 Medical Stores Limited (MSL) Bridging Support. Initiativet kommer i f&#xF6;rsta hand att fokusera p&#xE5; tekniskt bist&#xE5;nd till MSL, regeringen f&#xF6;retag som ansvarar f&#xF6;r upphandling, f&#xF6;rvaring och distribution av l&#xE4;kemedel och f&#xF6;rn&#xF6;denheter. Syftet med det tekniska st&#xF6;det fr&#xE5;n synvinkel MSL, &#xE4;r att hj&#xE4;lpa MSL att utveckla ett h&#xE5;llbart statligt bolag som inte &#xE4;r beroende av st&#xF6;d fr&#xE5;n regeringen eller donatorer

Arbetet bygger p&#xE5; regeringens direktiv att alla statliga bolag ska vara sj&#xE4;lvf&#xF6;rs&#xF6;rjande. MSL antas har &#xF6;verkapacitet som skulle kunna utnyttjas f&#xF6;r att generera inkomster fr&#xE5;n andra servicesektorer. Dessa inkomster skulle kunna st&#xF6;dja MSLs k&#xE4;rnverksamhet som &#xE4;r f&#xF6;rvaring och distribution av l&#xE4;kemedel. Det finns en risk att MSL inte kommer att kunna generera tillr&#xE4;ckligt med kapital f&#xF6;r att klara sin verksamhet och att bolages fokus kommer att ligga p&#xE5; inkomstgenererande f&#xF6;retagsverksamhet och inte MSLs k&#xE4;rnverksamheten som idag inte fungerar optimalt. Det &#xE4;r d&#xE4;rf&#xF6;r h&#xF6;g risk att resultaten inte kommer att uppfyllas och att bidraget skulle kunna leda till o&#xF6;nskade biverkningar s&#xE5;som f&#xF6;rsummelse av MSLs k&#xE4;rnverksamhet som &#xE4;r av intresse f&#xF6;r att uppn&#xE5; h&#xE4;lsoresultaten i Sveriges resultatstrategi f&#xF6;r Zambia.

Tv&#xE5; tekniska konsulter f&#xF6;resl&#xE5;s enligt f&#xF6;ljande:

1.	R&#xE5;dgivare f&#xF6;r strategiska allianser med syftet att underl&#xE4;tta genomf&#xF6;randet av MSLs aff&#xE4;rsplan f&#xF6;r kommersialisering genom att identifiera och skapa strategiska allianser och partnerskap som kan s&#xE4;kra MSLs sj&#xE4;lvf&#xF6;rs&#xF6;rjande st&#xE4;llning, och d&#xE4;rmed s&#xE4;kra MSLs tj&#xE4;nster till den offentliga h&#xE4;lso- och sjukv&#xE5;rdssektorn
2.	R&#xE5;dgivare f&#xF6;r MSLs kommersialisering med m&#xE5;let att utveckla en aff&#xE4;rsmodell som kommer att fungera som en plattform f&#xF6;r att utveckla MSL till ett h&#xE5;llbart f&#xF6;retag i samarbete med b&#xE5;de den offentliga och privata sektorn. 

Tj&#xE4;nsterna kommer att &#xF6;vervakas i enlighet med den &#xF6;verenskomna uppdragsbeskrivningen och ramavtal/avrop med InDevelop.</narrative>
   <narrative xml:lang="EN">The intervention is supportive of contribution number 51190097 Medical Stores Limited (MSL) Bridging Support.   This intervention will primarily focus on provision of technical assistance to MSL, the government entity responsible for procurement, storage and distribution of essential medicines and supplies. to help make it financially sustainable.   The goal of the technical assistance from the point of view of MSL, is to help MSL lay the ground work to develop a self- sustaining corporation that is not dependent on government or donor Grants is able to finance its operations sustainably and predictably. 

The work is based on government directive that all parastatal companies should be self-financing. The assumptions are that MSL has excess capacity that could be made use of to generate ample income to support the core business which is drug storage and distribution and that there is potential market for the services.  The risks are that MSL will not be able to generate sufficient capital to manage its operation and that the diverted focus on entrepreneurial activities will draw attention away from the core business where the performance is currently less than optimal.  .    There is therefore high risk that the results will not be met and that the contribution as such would result in undesirable side effects such as a total neglect of the core business which is of interest to the achievement of results under improved health in Sweden&#x2019;s results strategy for Zambia. 


Two technical assistants are proposed as follows;

1.	Strategic Alliances Advisor with the objective  to assist in the implementation of the MSL commercialisation business plan through identifying and creating strategic alliances / partnerships that will secure MSL self- sustaining position, and thereby secure MSL&apos;s services to the public health sector:

2.	The Commercialisation Technical Advisor with the objective is to formulate a business model that will serve as a platform from which to launch the transformation of MSL into a sustainable enterprise in partnership with both public and private sector participation. 

The services will be monitored in accordance to the agreed ToRs and framework agreement/call off with indevelop</narrative>
  </description>
  <participating-org ref="90000" role="4" type="90">
   <narrative xml:lang="EN">InDevelop-IPM</narrative>
  </participating-org>
  <participating-org ref="90000" role="2">
   <narrative xml:lang="EN">Medical Stores Ltd</narrative>
  </participating-org>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-6" role="3" type="10">
   <narrative xml:lang="EN">Swedish International Development Cooperation Agency</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2014-12-01" type="1"></activity-date>
  <activity-date iso-date="2014-12-01" type="2"></activity-date>
  <activity-date iso-date="2018-02-28" type="3"></activity-date>
  <activity-date iso-date="2018-02-28" type="4"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">Swedish International Development Cooperation Agency</narrative>
   </organisation>
   <telephone>+46 8 698 50 00</telephone>
   <email>sida@sida.se</email>
   <website>www.sida.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Valhallav&#xE4;gen 199, 105 25 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="ZM" percentage="100">
   <narrative xml:lang="EN">Zambia</narrative>
  </recipient-country>
  <sector code="122" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Basic Health</narrative>
  </sector>
  <sector code="12220" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Basic health care</narrative>
  </sector>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disability</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="1" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget>
   <period-start iso-date="2015-01-01"></period-start>
   <period-end iso-date="2015-12-28"></period-end>
   <value currency="USD" value-date="2015-01-01">243517.8484571673</value>
  </budget>
  <budget>
   <period-start iso-date="2016-01-01"></period-start>
   <period-end iso-date="2016-12-28"></period-end>
   <value currency="USD" value-date="2016-01-01">63964.8220650967</value>
  </budget>
  <budget>
   <period-start iso-date="2017-01-01"></period-start>
   <period-end iso-date="2017-12-28"></period-end>
   <value currency="USD" value-date="2017-01-01">-149401.8954018954</value>
  </budget>
  <budget>
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-12-28"></period-end>
   <value currency="USD" value-date="2018-01-01">146936.6197183098</value>
  </budget>
  <planned-disbursement>
   <period-start iso-date="2015-01-01"></period-start>
   <period-end iso-date="2015-12-28"></period-end>
   <value currency="USD" value-date="2015-01-01">273589.0287449729</value>
  </planned-disbursement>
  <planned-disbursement>
   <period-start iso-date="2016-01-01"></period-start>
   <period-end iso-date="2016-12-28"></period-end>
   <value currency="USD" value-date="2016-01-01">34340.6766785485</value>
  </planned-disbursement>
  <planned-disbursement>
   <period-start iso-date="2017-01-01"></period-start>
   <period-end iso-date="2017-12-28"></period-end>
   <value currency="USD" value-date="2017-01-01">-149401.8954018954</value>
  </planned-disbursement>
  <planned-disbursement>
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-12-28"></period-end>
   <value currency="USD" value-date="2018-01-01">146936.6197183098</value>
  </planned-disbursement>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2014-12-01"></transaction-date>
   <value currency="USD" value-date="2014-12-01">379014.271345</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-08-28"></transaction-date>
   <value currency="USD" value-date="2015-08-28">47575.0062282752</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-09-28"></transaction-date>
   <value currency="USD" value-date="2015-09-28">49613.7283048414</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-10-28"></transaction-date>
   <value currency="USD" value-date="2015-10-28">17643.3393045686</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-11-28"></transaction-date>
   <value currency="USD" value-date="2015-11-28">77819.9850521396</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-12-28"></transaction-date>
   <value currency="USD" value-date="2015-12-28">50865.7895673425</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-03-28"></transaction-date>
   <value currency="USD" value-date="2016-03-28">34340.6766785485</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-05-28"></transaction-date>
   <value currency="USD" value-date="2016-05-28">0</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-07-28"></transaction-date>
   <value currency="USD" value-date="2017-07-28">-78429.8642798643</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-11-28"></transaction-date>
   <value currency="USD" value-date="2017-11-28">-70972.0545220545</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-02-28"></transaction-date>
   <value currency="USD" value-date="2018-02-28">146936.6197183098</value>
  </transaction>
  <crs-add>
   <other-flags code="1" significance="1"></other-flags>
  </crs-add>
  <sida:contribution contributionid="51190111" xmlns:sida="http://sida.se/ns/contribution#"></sida:contribution>
 </iati-activity>
</iati-activities>
